Navigation Links
Studies of Drug Resistance May Lead to Individual Therapy for Rare,Cancers

WASHINGTON, January 29, 2007 /PRNewswire-USNewswire/ -- Rear Admiral Timothy Ziemer (U.S. Navy, retired), the President's Malaria Coordinator, announced his intent to name Dr. Bernard Nahlen to serve as Deputy Coordinator of the President's Malaria Initiative (PMI). Dr. Nahlen is a Commissioned Officer in the U.S. Public Heath Service and has most recently served as Senior Advisor, Monitoring and Evaluation, at the Global Fund to Fight AIDS, Tuberculosis and Malaria.

As Deputy Coordinator, Dr. Nahlen will assist the Coordinator in directing the PMI, an historic $1.2 billion, five-year initiative announced by President Bush in 2005 to control malaria in Africa. His specific responsibilities will include serving as the Senior Technical Advisor to the Coordinator providing guidance on malaria technical issues and program interventions; assisting in country programs, program facilitation, policy coordination, coherence and implementation among all U.S. Government (USG) agencies and other recipients of USG funds for malaria prevention and treatment.

The goal of the PMI is to assist national malaria control programs to cut malaria-related deaths by 50 percent in fifteen target countries in Africa. This goal will be achieved by reaching 85 percent of the most vulnerable groups -- children under five years of age and pregnant women -- with proven and effective prevention and treatment control measures. PMI uses a comprehensive approach to prevent and treat malaria supporting four key areas; indoor spraying of homes with insecticides, insecticide-treated mosquito nets, lifesaving anti-malarial drugs, and treatment to prevent malaria in pregnant women. The initiative is a collaborative USG effort led by the U.S. Agency for International Development (USAID), in conjunction with the Department of Health and Human Services (Centers for Disease Control and Prevention), the Department of State, the White House,
'"/>




Page: 1 2

Related medicine technology :

1. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
2. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
3. Cyclacel Pharmaceuticals Announces Results of Phase II Seliciclib Combination Studies
4. Insmed Inc. Welcomes Studies Linking IGFBP-3 to Prevention of Blindness in Premature Infants
5. Resveratrol Studies Suggest Broad Implications for SIRT1 Activation in Neurodegenerative Diseases of Aging Such as Alzheimers Disease
6. Publication on Pixantrone Preclinical Studies Demonstrates Reduced Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and Mitoxantrone
7. Phosphagenics Announces Positive Proof of Concept Results from Studies Utilizing Companys Dermal Drug Delivery Technology
8. New Data from Multiple Studies Show Galvus Delivers Consistent and Robust Blood Sugar Control in Patients with Type 2 Diabetes
9. Eurands Zentase Effective in Treating Exocrine Pancreatic Insufficiency, Studies Show
10. Three Studies Suggest Abbotts Humira (adalimumab) May Improve Work Productivity in Patients with Rheumatoid Arthritis
11. Neurogen Proprietary Insomnia Compound Data for Two Studies Presented at Associated Professional Sleep Societies Annual Meeting

Post Your Comments:
(Date:11/20/2009)... MINNEAPOLIS, Nov. 20 Bi...ults for its first quarter ended September 30, 200...ted share, on revenues of $3,263,000. This compar...ed share, on revenues of $3,168,000 for the first ...t quarter results, Biotel President and CEO Steve ...
(Date:11/20/2009)..., FRANKLIN LAKES, N.J., Nov. 20 /PRNewswire-FirstC... BDX ) today announced the completion of its acqu...based company that develops and manufactures molec..., In May 2009, BD and HandyLab announced an exc...ze molecular assays on the HandyLab Jaguar(TM) pla...
(Date:11/19/2009)..., ARDEE, Ireland, Nov. 19 Warner ...pricing of its previously announced secondary offe...ce to the public of $22.25 per share. The selling...apital Partners, DLJ Merchant Banking, J.P. Morgan...Lee Partners, L.P., certain other institutional in...
Breaking Medicine Technology:Biotel Announced Profitable First Quarter Ended September 30, 2009 2BD Completes Acquisition of HandyLab, Inc. 2BD Completes Acquisition of HandyLab, Inc. 3Warner Chilcott Prices Secondary Equity Offering 2Warner Chilcott Prices Secondary Equity Offering 3Warner Chilcott Prices Secondary Equity Offering 4Lupin Expands Branded Play 5066 1Lupin Expands Branded Play 5066 2Lupin Expands Branded Play 5066 3Sexually satisfied women have better general well being and more vitality 58485 1Sexually satisfied women have better general well being and more vitality 58485 2Sexually satisfied women have better general well being and more vitality 58485 3Is trash the solution to tackling climate change 3F 14282 1
...E) -- MGI PHARMA, INC.,(NASDAQ:MOGN), a biopharmac..., today announced the presentation of results of a...ospropofol,disodium) Injection in patients undergo...dpoint results, as well as safety data, were,prese... D.C. by,Lawrence B. Cohen, MD, Department of Medi...
...ms and Urine Flow, With,Long Lasting Effect in Pha...re-FirstCall/ -- Spectrum,Pharmaceuticals, Inc., t...r ozarelix, the Company,s drug candidate for the t... the American Urology,Association Annual Meeting h...alifornia on Tuesday, May 22, 2007. , "The results...
Other Medicine Technology:Aquavan (Fospropofol Disodium) Injection Data Presented at,Digestive Disease Week 2007 2Aquavan (Fospropofol Disodium) Injection Data Presented at,Digestive Disease Week 2007 3Aquavan (Fospropofol Disodium) Injection Data Presented at,Digestive Disease Week 2007 4Aquavan (Fospropofol Disodium) Injection Data Presented at,Digestive Disease Week 2007 5Ozarelix Phase 2 Data in Benign Prostatic Hypertrophy Presented at,Annual Meeting of American Urological Association 2Ozarelix Phase 2 Data in Benign Prostatic Hypertrophy Presented at,Annual Meeting of American Urological Association 3Ozarelix Phase 2 Data in Benign Prostatic Hypertrophy Presented at,Annual Meeting of American Urological Association 4Ozarelix Phase 2 Data in Benign Prostatic Hypertrophy Presented at,Annual Meeting of American Urological Association 5
(Date:11/21/2009)... Innovative medical apparel company launch... San Clemente, Calif. (PRWEB)...kthrough medical apparel, today announced the laun... Medica 2009, a leading international trade fair f...y. Medelita inaugurates its men,s collection with ...
(Date:11/21/2009)... Linwood Group ask whether there is a secr...ed? , London, UK (PRWEB) ...h up to one in three of the adult UK population dr...ng alcohol-related liver disease*, it is hardly a ...abilitation programmes and residential centres for...
(Date:11/20/2009)...ASHINGTON, Nov. 20 The ... the Senate to make essential changes its health r...n abortion funding and conscience protection on ab...ts and include strong provisions for adequate affo...lth care bill an "enormous disappointment" that cr...
(Date:11/20/2009)...O, Nov. 20 The American...d and Drug Administration (FDA) to establish appro...ls. ,, Citing concern about the safety of whit... the benefit of professional consultation or exami... application of chemically based tooth whitening o...
(Date:11/20/2009)...AS, Nov. 20 The followi...ctor of the Nevada Health Care Association: ,, ...s and thanks Senate Majority Leader Harry Reid for... toward our goal of protecting every Nevada senior...d preserving the strength and viability of our sta...
Breaking Medicine News(10 mins):Health News:Medelita Introduces Men's Lab Coat Collection 2Health News:Medelita Introduces Men's Lab Coat Collection 3Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 2Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 3Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 4Health News:U.S. Bishops Voice Disappointment in Abortion-Funding Provisions in Senate Health Bill, Urge Better Care for Immigrants and Affordability 2Health News:American Dental Association Petitions FDA to Classify, Regulate Tooth-Whitening Products 2
...lar disorder respond differently to facial express...according to a new study led by a Bradley Hospital...insight into the neurobiology of pediatric bipolar...isorder in kids, our understanding of its neurobio...
...versity of Pennsylvania School of Medicine and oth...ic stimulation (TMS) a non-invasive technique tha... passed through the scalp is a safe and effective...udy the largest to-date studying TMS as a standal...
...more dense breasts, , , MONDAY, Nov. 26 (H...pear to have more dense breast tissue than their s...ts. , The finding is potentially important because...n the United Kingdom, found that city-dwelling wom...
...king-related, and its there in bright medical imag... in the lungs, caused by secondhand cigarette smok... lung injury to nonsmokers that was long suspected...strict secondhand smoke. , We used a special typ...
...hers have identified structural damage to the lung...sults of the study, conducted by researchers at th...rlottesville and The Childrens Hospital of Philade...hat prolonged exposure to secondhand smoke may cau...
... RN, FAAN, FAHA, a clinical professor of neurology...d an investigator at the Framingham Heart Study, w...the American Heart Association (AHA). The award wa...ely work to integrate stroke and heart disease in ...
Other Medicine News:Health News:Facial expressions have greater impact on kids with bipolar disorder 2Health News:Penn research shows transcranial magnetic stimulation effective in treating major depression 2Health News:Urban Women May Have Greater Breast Cancer Risk 2Health News:Urban Women May Have Greater Breast Cancer Risk 3Health News:Secondhand smoke damages lungs, MRIs show 2Health News:Novel MRI technique shows secondhand smoke damages lungs 2
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
Medicine Products: